Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immune cells track hard-to-target brain tumours.

Literature DB >> 30622348

Immune cells track hard-to-target brain tumours.

Neeha Zaidi, Elizabeth M Jaffee.

Abstract

Entities: Chemical

Keywords: Cancer; Immunology

Mesh：

Substances：
Vaccines

Year: 2019 PMID： 30622348 PMCID： PMC6532058 DOI： 10.1038/d41586-018-07728-9

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 69.504

× No keyword cloud information.

7 in total

Review 1. Targeting neoantigens to augment antitumour immunity.

Authors: Mark Yarchoan; Burles A Johnson; Eric R Lutz; Daniel A Laheru; Elizabeth M Jaffee
Journal: Nat Rev Cancer Date: 2017-02-24 Impact factor: 60.716

2. Tumor Mutational Burden and Response Rate to PD-1 Inhibition.

Authors: Mark Yarchoan; Alexander Hopkins; Elizabeth M Jaffee
Journal: N Engl J Med Date: 2017-12-21 Impact factor: 91.245

3. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Authors: Jedd D Wolchok; Vanna Chiarion-Sileni; Rene Gonzalez; Piotr Rutkowski; Jean-Jacques Grob; C Lance Cowey; Christopher D Lao; John Wagstaff; Dirk Schadendorf; Pier F Ferrucci; Michael Smylie; Reinhard Dummer; Andrew Hill; David Hogg; John Haanen; Matteo S Carlino; Oliver Bechter; Michele Maio; Ivan Marquez-Rodas; Massimo Guidoboni; Grant McArthur; Celeste Lebbé; Paolo A Ascierto; Georgina V Long; Jonathan Cebon; Jeffrey Sosman; Michael A Postow; Margaret K Callahan; Dana Walker; Linda Rollin; Rafia Bhore; F Stephen Hodi; James Larkin
Journal: N Engl J Med Date: 2017-09-11 Impact factor: 91.245

4. An immunogenic personal neoantigen vaccine for patients with melanoma.

Authors: Patrick A Ott; Zhuting Hu; Derin B Keskin; Sachet A Shukla; Jing Sun; David J Bozym; Wandi Zhang; Adrienne Luoma; Anita Giobbie-Hurder; Lauren Peter; Christina Chen; Oriol Olive; Todd A Carter; Shuqiang Li; David J Lieb; Thomas Eisenhaure; Evisa Gjini; Jonathan Stevens; William J Lane; Indu Javeri; Kaliappanadar Nellaiappan; Andres M Salazar; Heather Daley; Michael Seaman; Elizabeth I Buchbinder; Charles H Yoon; Maegan Harden; Niall Lennon; Stacey Gabriel; Scott J Rodig; Dan H Barouch; Jon C Aster; Gad Getz; Kai Wucherpfennig; Donna Neuberg; Jerome Ritz; Eric S Lander; Edward F Fritsch; Nir Hacohen; Catherine J Wu
Journal: Nature Date: 2017-07-05 Impact factor: 49.962

5. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.

Authors: Ugur Sahin; Evelyna Derhovanessian; Matthias Miller; Björn-Philipp Kloke; Petra Simon; Martin Löwer; Valesca Bukur; Arbel D Tadmor; Ulrich Luxemburger; Barbara Schrörs; Tana Omokoko; Mathias Vormehr; Christian Albrecht; Anna Paruzynski; Andreas N Kuhn; Janina Buck; Sandra Heesch; Katharina H Schreeb; Felicitas Müller; Inga Ortseifer; Isabel Vogler; Eva Godehardt; Sebastian Attig; Richard Rae; Andrea Breitkreuz; Claudia Tolliver; Martin Suchan; Goran Martic; Alexander Hohberger; Patrick Sorn; Jan Diekmann; Janko Ciesla; Olga Waksmann; Alexandra-Kemmer Brück; Meike Witt; Martina Zillgen; Andree Rothermel; Barbara Kasemann; David Langer; Stefanie Bolte; Mustafa Diken; Sebastian Kreiter; Romina Nemecek; Christoffer Gebhardt; Stephan Grabbe; Christoph Höller; Jochen Utikal; Christoph Huber; Carmen Loquai; Özlem Türeci
Journal: Nature Date: 2017-07-05 Impact factor: 49.962

6. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.

Authors: Simon F Lacey; Elena J Orlando; Joseph A Fraietta; Iulian Pruteanu-Malinici; Mercy Gohil; Stefan Lundh; Alina C Boesteanu; Yan Wang; Roddy S O'Connor; Wei-Ting Hwang; Edward Pequignot; David E Ambrose; Changfeng Zhang; Nicholas Wilcox; Felipe Bedoya; Corin Dorfmeier; Fang Chen; Lifeng Tian; Harit Parakandi; Minnal Gupta; Regina M Young; F Brad Johnson; Irina Kulikovskaya; Li Liu; Jun Xu; Sadik H Kassim; Megan M Davis; Bruce L Levine; Noelle V Frey; Donald L Siegel; Alexander C Huang; E John Wherry; Hans Bitter; Jennifer L Brogdon; David L Porter; Carl H June; J Joseph Melenhorst
Journal: Nat Med Date: 2018-04-30 Impact factor: 53.440

Review 7. Emerging strategies for combination checkpoint modulators in cancer immunotherapy.

Authors: Aleksandra Popovic; Elizabeth M Jaffee; Neeha Zaidi
Journal: J Clin Invest Date: 2018-08-01 Impact factor: 19.456

7 in total

1. Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot.

Authors: Zhaoting Li; Lianghan Zhu; Honghao Sun; Yuexin Shen; Dandan Hu; Wenhao Wu; Yixin Wang; Chenggen Qian; Minjie Sun
Journal: Proc Natl Acad Sci U S A Date: 2020-12-14 Impact factor: 11.205

2. Comprehensive Analysis of Sterol O-Acyltransferase 1 as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma.

Authors: Xuyang Guo; Shaolong Zhou; Zhuo Yang; Zi-An Li; Weihua Hu; Lirui Dai; Wulong Liang; Xinjun Wang
Journal: Front Oncol Date: 2022-05-12 Impact factor: 5.738

3. HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM).

Authors: Farzaneh Sharifzad; Soura Mardpour; Saeid Mardpour; Esmaeil Fakharian; Adeleh Taghikhani; Amirhossein Sharifzad; Sahar Kiani; Yasaman Heydarian; Marek J Łos; Zahra Azizi; Saeid Ghavami; Amir Ali Hamidieh; Marzieh Ebrahimi
Journal: Int J Mol Sci Date: 2020-03-25 Impact factor: 5.923

4. Highly Multiplexed Digital Spatial Profiling of the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Patients.

Authors: Arutha Kulasinghe; Touraj Taheri; Ken O'Byrne; Brett G M Hughes; Liz Kenny; Chamindie Punyadeera
Journal: Front Oncol Date: 2021-01-19 Impact factor: 6.244